Rofo 2012; 184(6): 503-512
DOI: 10.1055/s-0031-1299122
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Mechanische Thrombektomie beim akuten Schlaganfall

Mechanical Thrombectomy for Acute Ischemic Stroke
C. Brekenfeld
,
J. Gralla
,
C. Zubler
,
G. Schroth
Further Information

Publication History

24 July 2011

20 December 2011

Publication Date:
01 February 2012 (online)

Zusammenfassung

Ziel der Akuttherapie des ischämischen Schlaganfalls ist die rasche Rekanalisation der verschlossenen Hirnarterie. Endovaskuläre Verfahren haben insbesondere bei Verschlüssen großer Hirnarterien höhere Rekanalisationsraten als die intravenöse Thrombolyse (IVT). Die mechanische Thrombektomie mit dem Merci-Retriever ist daher seit 2004 von der FDA in Ergänzung zur IVT oder bei Kontraindikationen einer IVT bis 8 h nach Infarktbeginn zugelassen. Mit diesem System konnte eine Rekanalisationsrate von 55 % erreicht werden, sodass weiteres Verbesserungspotenzial bestand. Seit 2008 darf auch das Penumbra-System angewendet werden. Der neueste endovaskuläre Behandlungsansatz mit wieder entfernbaren intrakraniellen Stents zeigt die bisher höchsten Rekanalisationsraten von über 90 % bei gleichzeitiger Reduktion der Behandlungsdauer ohne zunehmende Komplikationsrate. Die bisherigen ermutigenden Ergebnisse legen eine kombinierte Therapie nahe, bei der eine IVT auch in kleineren Häusern begonnen werden kann, um dann in einem spezialisierten neuroradiologischen Zentrum bei persistierendem Verschluss durch die endovaskuläre Rekanalisation ergänzt zu werden (sog. Bridging-Therapie). Patienten außerhalb des 4,5 h-Zeitfensters für die IVT können bis 8 h nach Infarktbeginn mittels mechanischer Thrombektomie therapiert werden.

Abstract

The therapy of acute ischemic stroke aims at fast recanalization of the occluded brain vessel. In contrast to intravenous thrombolysis (IVT), endovascular approaches yield higher recanalization rates especially in large vessel occlusions. Mechanical thrombectomy with the Merci Retriever received FDA approval in 2004 as an adjunct to IVT or in the case of failed recanalization after IVT. The time window for treatment is 8 h from stroke onset. However, the recanalization rate was 55 %, still leaving space for further improvement. In addition to the Merci Retriever, the Penumbra System received FDA approval in 2008. The newest endovascular approach comprising retrievable intracranial stents results in an increased recanalization rate exceeding 90 % and has markedly reduced the time to recanalization. On the other hand, the complication rate has not increased yet. These promising results suggest a combined therapy for acute ischemic stroke. In a first step IVT can be started independently of the size of the treating hospital and in a next step the patient is transferred to a neuroradiological center. If vessel occlusion persists, additional endovascular recanalization is performed (bridging concept). Patients who don‘t qualify for IVT are candidates for mechanical thrombectomy up to 8 h after stroke onset.

 
  • Literatur

  • 1 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587
  • 2 Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329
  • 3 Barber PA, Zhang J, Demchuk AM et al. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001; 56: 1015-1020
  • 4 Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007; 38: 967-973
  • 5 Riedel CH, Zimmermann P, Jensen-Kondering U et al. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011; 42: 1775-1777
  • 6 del Zoppo GJ, Poeck K, Pessin MS et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32: 78-86
  • 7 Mori E, Yoneda Y, Tabuchi M et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992; 42: 976-982
  • 8 Saqqur M, Uchino K, Demchuk AM et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38: 948-954
  • 9 Bhatia R, Hill MD, Shobha N et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: Real-world experience and a call for action. Stroke 2010; 41: 2254-2258
  • 10 Furlan A, Higashida R, Wechsler L et al. Intra-arterial proUK for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003-2011
  • 11 Arnold M, Schroth G, Nedeltchev K et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002; 33: 1828-1833
  • 12 Ogawa A, Mori E, Minematsu K et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007; 38: 2633-2639
  • 13 Lewandowski CA, Frankel M, Tomsick TA et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999; 30: 2598-2605
  • 14 Brekenfeld C, Remonda L, Nedeltchev K et al. Symptomatic intracranial haemorrhage after intra-arterial thrombolysis in acute ischaemic stroke: assessment of 294 patients treated with urokinase. J Neurol Neurosurg Psychiatry 2007; 78: 280-285
  • 15 Barnwell SL, Clark WM, Nguyen TT et al. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. Am J Neuroradiol 1994; 15: 1817-1822
  • 16 Sorimachi T, Fujii Y, Tsuchiya N et al. Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. Am J Neuroradiol 2004; 25: 1391-1402
  • 17 Noser EA, Shaltoni HM, Hall CE et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke?. Stroke 2005; 36: 292-296
  • 18 Mazighi M, Serfaty JM, Labreuche J et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009; 8: 802-809
  • 19 Brekenfeld C, Gralla J, Mattle HP et al. Thrombolyse der Arteria cerebri media. Radiologe 2009; 49: 312-318
  • 20 Eckert B. Acute stroke therapy 1981–2009. Klin Neuroradiol 2009; 19: 8-19
  • 21 Chapot R, Houdart E, Rogopoulos A et al. Thromboaspiration in the basilar artery: report of two cases. Am J Neuroradiol 2002; 23: 282-284
  • 22 Lutsep HL, Clark WM, Nesbit GM et al. Intraarterial suction thrombectomy in acute stroke. Am J Neuroradiol 2002; 23: 783-786
  • 23 Nedeltchev K, Remonda L, Do DD et al. Acute stenting and thromboaspiration in basilar artery occlusions due to embolism from the dominating vertebral artery. Neuroradiology 2004; 46: 686-691
  • 24 Kang DH, Hwang YH, Kim YS et al. Direct thrombus retrieval using the reperfusion catheter of the penumbra system: forced-suction thrombectomy in acute ischemic stroke. Am J Neuroradiol 2011; 32: 283-287
  • 25 Gralla J, Schroth G, Remonda L et al. Mechanical thrombectomy for acute ischemic stroke: thrombus-device interaction, efficiency, and complications in vivo. Stroke 2006; 37: 3019-3024
  • 26 Mayer TE, Hamann GF, Brueckmann HJ. Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal. Stroke 2002; 33: 2232-2235
  • 27 Berlis A, Lutsep H, Barnwell S et al. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 2004; 35: 1112-1126
  • 28 Mayer TE, Hamann GF, Schulte-Altedorneburg G et al. Treatment of vertebrobasilar occlusion by using a coronary waterjet thrombectomy device: a pilot study. Am J Neuroradiol 2005; 26: 1389-1394
  • 29 Chapot R. First experience with the CATCH, a new device for cerebral thrombectomy. Interventional Neuroradiology 2005; 11: 56-58
  • 30 Liebig T, Reinartz J, Hannes R et al. Comparative in vitro study of five mechanical embolectomy systems: effectiveness of clot removal and risk of distal embolization. Neuroradiology 2008; 50: 43-52
  • 31 Hussain MS, Kelly ME, Moskowitz SI et al. Mechanical thrombectomy for acute stroke with the alligator retrieval device. Stroke 2009; 40: 3784-3788
  • 32 Mordasini P, Hiller M, Brekenfeld C et al. In vivo evaluation of the Phenox CRC mechanical thrombectomy device in a swine model of acute vessel occlusion. Am J Neuroradiol 2010; 31: 972-978
  • 33 Bellon RJ, Putman CM, Budzik RF et al. Rheolytic thrombectomy of the occluded internal carotid artery in the setting of acute ischemic stroke. Am J Neuroradiol 2001; 22: 526-530
  • 34 Mahon BR, Nesbit GM, Barnwell SL et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. Am J Neuroradiol 2003; 24: 534-538
  • 35 Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432-1438
  • 36 Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39: 1205-1212
  • 37 Wahlgren N, Ahmed N, Eriksson N et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008; 39: 3316-3322
  • 38 Bose A, Henkes H, Alfke K et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. Am J Neuroradiol 2008; 29: 1409-1413
  • 39 The Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40: 2761-2768
  • 40 Kulcsár Z, Bonvin C, Pereira VM et al. Penumbra System: A Novel Mechanical Thrombectomy Device for Large-Vessel Occlusions in Acute Stroke. Am J Neuroradiol 2010; 31: 628-633
  • 41 Brekenfeld C, Tinguely P, Schroth G et al. Percutaneous transluminal angioplasty and stent placement in acute vessel occlusion: Evaluation of new methods for interventional stroke treatment. Am J Neuroradiol 2009; 30: 1165-1172
  • 42 Ueda T, Hatakeyama T, Kohno K et al. Endovascular treatment for acute thrombotic occlusion of the middle cerebral artery: local intra-arterial thrombolysis combined with percutaneous transluminal angioplasty. Neuroradiology 1997; 39: 99-104
  • 43 Ringer AJ, Qureshi AI, Fessler RD et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001; 48: 1282-1288
  • 44 Nakano S, Iseda T, Yoneyama T et al. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 2002; 33: 2872-2876
  • 45 Levy EI, Ecker RD, Horowitz MB et al. Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 2006; 58: 458-463
  • 46 Levy EI, Mehta R, Gupta R et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. Am J Neuroradiol 2007; 28: 816-822
  • 47 Zaidat OO, Wolfe T, Hussain SI et al. Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke 2008; 39: 2392-2395
  • 48 Brekenfeld C, Schroth G, Mattle HP et al. Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment. Stroke 2009; 40: 847-852
  • 49 Levy EI, Siddiqui AH, Crumlish A et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009; 40: 3552-3556
  • 50 Albuquerque FC, Levy EI, Turk AS et al. Angiographic patterns of Wingspan in-stent restenosis. Neurosurgery 2008; 63: 23-27
  • 51 Castano C, Dorado L, Guerrero C et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010; 41: 1836-1840
  • 52 Roth C, Papanagiotou P, Behnke S et al. Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 2010; 41: 2559-2567
  • 53 Brekenfeld C, Schroth G, Mordasini P et al. Impact of retrievable stents on acute ischemic stroke treatment. Am J Neuroradiol 2011; 32: 1264-1273
  • 54 Menon BK, Kochar P, Ah-Seng A et al. Initial experience with a self-expandfing retrievable stent for recanalization of large vessel occlusions in acute ischemic stroke. Neuroradiology 2011; Epub ahead of print
  • 55 Mordasini P, Frabetti N, Gralla J et al. In-vivo evaluation of a dedicated combined flow restoration and mechanical thrombectomy device in a swine model of acute vessel occlusion. Am J Neuroradiol 2010; 32: 294-300
  • 56 Miteff F, Faulder KC, Goh ACC et al. Mechanical thrombectomy with a self-expanding retrievable intracranial stent (Solitaire AB): Experience in 26 patients with acute cerebral artery occlusion. Am J Neuroradiol 2011; 32: 1078-1081